Puma Biotechnology Inc (NYSE:PBYI) on March 12 announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 11:45 a.m. EDT on Wednesday, March 19, at the Bank of America Merrill Lynch 2014 Smid Cap Conference. The conference will be held at The Ritz-Carlton, Boston Common. Puma Biotechnology Inc (NYSE:PBYI) shares after opening at $104.30on last trade day and at the end of the day closed at $112.36. Company price to cash ratio in past twelve months was calculated as 40.34. Puma Biotechnology Inc (NYSE:PBYI) showed a positive weekly performance of 0.82%.
Theravance Inc (NASDAQ:THRX) announced the appointment of Kevin Kwok as Head of Talent Acquisition and Strategy. Dr. Kwok will be responsible for leading the Company’s efforts in talent acquisition and talent management and implementation of the strategies in these areas across the organization. Theravance Inc (NASDAQ:THRX) shares advanced 1.26% in last trading session and ended the day on $31.33. THRX return on equity ratio is recorded as -103.20% and its return on assets is -32.90%. Theravance Inc (NASDAQ:THRX) yearly performance is 29.20%.
Darrell Cavens, the 41-year-old chief executive officer of Zulily Inc (NASDAQ:ZU)., has become a billionaire as the online retailer has rallied 58 percent this year. Cavens, who co-founded Zulily in 2009 with the company’s billionaire chairman, Mark Vadon, has a 17 percent economic interest in the business, a stake valued at $1.4 billion, according to the Bloomberg Billionaires Index. He also owns about 4 million stock options that began vesting last May. Zulily Inc (NASDAQ:ZU) shares moved up 10.36% in last trading session and was closed at $55.39, while trading in range of $50.50 – $56.81. Zulily Inc (NASDAQ:ZU) year to date (YTD) performance is 33.70%.
An effort to sell Anixter International Inc. (NYSE:AXE), the wiring parts maker that counts billionaire Sam Zell among its investors, has stalled as potential buyers reject the company’s price expectations, according to several people familiar with the matter. Anixter International Inc. (NYSE:AXE) weekly performance is -4.64%. On last trading day company shares ended up $96.45. Anixter International Inc. (NYSE:AXE) distance from 50-day simple moving average (SMA50) is -2.56%. Analysts mean target price for the company is $102.83.